← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 1.00 Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 1.00 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.99 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 Beta-frequency entrainment therapy targeting PV interneuron- (SST) — 0.99 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.99 Closed-loop tACS targeting EC-II parvalbumin interneurons to (PVALB) — 0.98 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 LRP1-Dependent Tau Uptake Disruption (LRP1) — 0.98 Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte (SST, SSTR1, SSTR2) — 0.97 TREM2-Dependent Microglial Senescence Transition (TREM2) — 0.95 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 (CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes) — 0.94 Dual-Receptor Antibody Shuttling (%s) — 0.94 SASP-Driven Microglial Metabolic Reprogramming in Synaptic P (HK2/PFKFB3) — 0.93 Multi-Biomarker Composite Index Surpassing Amyloid PET for T (COMPOSITE_BIOMARKER) — 0.93 Closed-loop transcranial alternating current stimulation to (SST) — 0.93 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Closed-loop tACS targeting entorhinal cortex layer II SST in (SST) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 TREM2-mediated microglial tau clearance enhancement (TREM2) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91
Add
|
× CX3CR1 Promoter Methylati × Fractalkine Axis Amplific
CX3CR1 · developmental neurobiology · -
Composite 0.640
Price $0.64
Evidence For 0
Evidence Against 0
Perinatal cytokines, particularly IL-6, may induce lasting CpG methylation at the CX3CR1 promoter through mechanisms including altered DNA methyltransferase activity (PMID:22580505). This could reduce microglial CX3CR1 expression, disrupting fractalkine signaling, impairing surveillance, and potentially removing the neuronal 'off signal,' leading to chronic neurotoxic microglial phenotypes in aging. Supporting this, CX3CR1 deficiency in mice worsens excitotoxicity and Alzheimer disease-related p
CX3CR1 · neurodegeneration · mechanistic
Composite 0.739
Price $0.76
Evidence For 0
Evidence Against 0
**Molecular Mechanism and Rationale**
The fractalkine/CX3CR1 signaling axis represents a critical communication pathway between neurons and microglia that maintains homeostatic brain function through precise regulation of microglial activity states. Fractalkine (CX3CL1) is a unique chemokine that exists in both membrane-bound and soluble forms, with the membrane-bound form serving as the primary ligand for the CX3CR1 receptor exclusively expressed on microglia in the central nervous system. Und
Verdict Summary 6/10
dimensions won
CX3CR1 Promoter Methylation Disrupts Neu
4/10
dimensions won
Fractalkine Axis Amplification via CX3CR
Radar Chart — 10 Dimensions
Score Breakdown
Dimension CX3CR1 Promoter Methylation Di Fractalkine Axis Amplification Mechanistic 0.750 0.650 Evidence 0.720 0.600 Novelty 0.650 0.800 Feasibility 0.700 0.500 Impact 0.580 0.700 Druggability 0.520 0.750 Safety 0.600 0.550 Competition 0.550 0.850 Data 0.680 0.600 Reproducible 0.650 0.550
Evidence CX3CR1 Promoter Methylation Disrupts Neuron-Microglia Cross- No evidence citations yet
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri No evidence citations yet
Debate Excerpts CX3CR1 Promoter Methylation Disrupts Neuron-Microg 4 rounds · quality: 0.71
Theorist # Mechanistic Hypotheses: Perinatal Immune Priming and Alzheimer's Disease
## Hypothesis 1: TREM2 Promoter Silencing via DNA Hypermethylation
**Mechanism:** Maternal immune activation (MIA) during c...
Skeptic # Critical Evaluation of Perinatal Immune Priming Hypotheses in Alzheimer's Disease
## Overview
These hypotheses propose mechanistic links between perinatal immune activation (MIA) and late-onset Al...
Domain Expert # Feasibility Assessment: Perinatal Immune Priming Hypotheses in Alzheimer's Disease
## Executive Summary
The seven mechanistic hypotheses proposing developmental origins for Alzheimer's disease via...
Synthesizer {
"ranked_hypotheses": [
{
"title": "CX3CR1 Promoter Methylation Disrupts Neuron-Microglia Cross-Talk",
"description": "Perinatal cytokines (IL-6) induce lasting CpG methylation at t...
Fractalkine Axis Amplification via CX3CR1 Positive 4 rounds · quality: 0.95
Theorist # Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease
## Hypothesis 1: Complement C1q Mimetic Decoy Therapy
**Description:** Engineer synthetic C1q mimetics that bind to sy...
Theorist # Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease
## Hypothesis 1: Complement C1q Mimetic Decoy Therapy
**Description:** Engineer synthetic C1q mimetics that bind to sy...
Skeptic # Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses
## Hypothesis 1: Complement C1q Mimetic Decoy Therapy
**Specific Weaknesses:**
- **Selectivity Problem:** C1q has essential physiolog...
Skeptic # Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses
## Hypothesis 1: Complement C1q Mimetic Decoy Therapy
**Specific Weaknesses:**
- **Selectivity Problem:** C1q has essential physiolog...
Price History Overlay
Knowledge Graph Comparison
CX3CR1 Promoter Methylation Disrupts Neu
0 edges
Top Node Types
Top Relations
Fractalkine Axis Amplification via CX3CR
79 edges
Top Node Types gene 68
hypothesis 7
pathway 2
process 2
Top Relations co_discussed 41
co_associated_with 15
implicated_in 7
participates_in 4
associated_with 3